Literature DB >> 11084041

Phosphorylation of the pro-apoptotic protein BIK: mapping of phosphorylation sites and effect on apoptosis.

S Verma1, L J Zhao , G Chinnadurai.   

Abstract

BIK is a pro-apoptotic BCL-2 family member and is the founding member of a subfamily of pro-apoptotic proteins known as "BH3-alone" proteins. Ectopic expression of BIK induces apoptosis in variety of mammalian cells. BIK complexes with various anti-apoptotic BCL-2 family proteins such as adenovirus E1B-19K and BCL-2 via the BH3 domain. However, the heterodimerization activity of BIK alone is insufficient for its apoptotic activity. Previous studies have shown that phosphorylation regulates the functional activity of both anti-apoptotic and pro-apoptotic members of the BCL-2 family. Here, we have examined phosphorylation of BIK and its effect on the apoptotic activity of BIK. We show that BIK exists as a phosphoprotein and is phosphorylated at residues 33 (threonine) and 35 (serine). Mutation of the phosphorylation sites, in which the Thr and Ser residues were changed to alanine residues, reduced the apoptotic activity of BIK without significantly affecting its ability to heterodimerize with BCL-2. Our results suggest that phosphorylation of BIK is required for eliciting efficient apoptotic activity. Partial purification of the protein kinase from HeLa cell cytoplasmic extracts suggest that BIK may be phosphorylated by a casein kinase II-related enzyme.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11084041     DOI: 10.1074/jbc.M008983200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

Review 1.  Cell Death Signaling.

Authors:  Douglas R Green; Fabien Llambi
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-12-01       Impact factor: 10.005

Review 2.  BH3-only proteins and their effects on cancer.

Authors:  Thanh-Trang Vo; Anthony Letai
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

3.  NBK/BIK antagonizes MCL-1 and BCL-XL and activates BAK-mediated apoptosis in response to protein synthesis inhibition.

Authors:  Tsutomu Shimazu; Kurt Degenhardt; Alam Nur-E-Kamal; Junjie Zhang; Takeshi Yoshida; Yonglong Zhang; Robin Mathew; Eileen White; Masayori Inouye
Journal:  Genes Dev       Date:  2007-04-02       Impact factor: 11.361

Review 4.  The impact of phosphatases on proliferative and survival signaling in cancer.

Authors:  Goutham Narla; Jaya Sangodkar; Christopher B Ryder
Journal:  Cell Mol Life Sci       Date:  2018-05-03       Impact factor: 9.261

5.  Mitochondria and the Bcl-2 family proteins in apoptosis signaling pathways.

Authors:  Bruno Antonsson
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

6.  Induction of cell death by the BH3-only Bcl-2 homolog Nbk/Bik is mediated by an entirely Bax-dependent mitochondrial pathway.

Authors:  Bernhard Gillissen; Frank Essmann; Vilma Graupner; Lilian Stärck; Silke Radetzki; Bernd Dörken; Klaus Schulze-Osthoff; Peter T Daniel
Journal:  EMBO J       Date:  2003-07-15       Impact factor: 11.598

7.  Protein phosphatase 2A dephosphorylation of phosphoserine 112 plays the gatekeeper role for BAD-mediated apoptosis.

Authors:  Chi-Wu Chiang; Cindy Kanies; Kwang Woon Kim; Wei Bin Fang; Christina Parkhurst; Minhui Xie; Travis Henry; Elizabeth Yang
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

Review 8.  BIK, the founding member of the BH3-only family proteins: mechanisms of cell death and role in cancer and pathogenic processes.

Authors:  G Chinnadurai; S Vijayalingam; R Rashmi
Journal:  Oncogene       Date:  2008-12       Impact factor: 9.867

Review 9.  BH3-only proteins in apoptosis and beyond: an overview.

Authors:  E Lomonosova; G Chinnadurai
Journal:  Oncogene       Date:  2008-12       Impact factor: 9.867

10.  Protein phosphatase 4 regulates apoptosis in leukemic and primary human T-cells.

Authors:  Mirna Mourtada-Maarabouni; Gwyn T Williams
Journal:  Leuk Res       Date:  2009-06-18       Impact factor: 3.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.